New cell implant aims to free type 1 diabetes patients from severe lows
Disease control
Terminated
This study tests a new treatment called SR-02, which uses insulin-making cells implanted in the abdomen (omentum) of adults with type 1 diabetes who have dangerous low blood sugar episodes. The goal is to see if the implant is safe and can help the body produce its own insulin ag…
Phase: PHASE1, PHASE2 • Sponsor: Seraxis • Aim: Disease control
Last updated May 11, 2026 20:41 UTC